Strategic Review30 Apr 2021 10:26
Good morning long time sufferers.
I was checking through old RNSs and nkted that on 18/2/21 they noted that a Strategic Review was to be undertaken to identify "how to employ the funds raised last year to focus on and develop the most attractive opportunities among the large number now presenting themselves, alongside the investment that has been required to manufacture masks". They also noted that this review should have been completed prior to announcement of the company accounts for the year 31 Dec 20.
2 questions here then. Its the end of Q1 21 so one would expect these accounts to have been published already or have I missed them.
Secondly, im wondering where the output of this strategic review is, again if ive not somehow missed it? Im guessing if not this is really the document that a lot of investors would want to see. It would no doubt also highlight progress with Pharm2Pharm and masks specifically? All speculation, but it would be poor form to announce that a review will be undertaken and then not announce the results? Understand its not incumbent upon them to announce if its not market sensitive but if it describes near term targets it may be? Interesting to hear people's thoughts on this?
Hoping for a rerate in any case. GLA